Ключевые слова:
peritonitis, complication, immunoprophylaxis.Библиографические ссылки
Akperov I.A., Butenko Yu.A., Gutsulyak A.I. Multistage operations in the treatment of diffuse purulent peritonitis // Fundamental and applied research in the modern world. — 2019. — No. 25. — Pp. 28–31. — EDN YYHMIP.
Ashurmettov A.M., Zhafarov H.M., Akhmedov M.D., et al. Lymphoimmunostimulation in diffuse purulent peritonitis // Young Scientist. — 2018. — No. 7(193). — Pp. 103–105. — EDN YPPKUY
Ackley R., Roshdy D., Meredith J., et al. Meropenem-vaborbactam versus ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae infections // Antimicrobial Agents and Chemotherapy. — 2020. — Vol. 64, No. 5. — Article e02313-19. DOI: 10.1128/AAC.02313-19.
Alosaimy S., Jorgensen S.C.J., Lagnf A.M., et al. Real-world multicenter analysis of clinical outcomes and safety of meropenem-vaborbactam in patients treated for serious gram-negative bacterial infections // Open Forum Infectious Diseases. — 2020. — Vol. 7, No. 3. — Article ofaa051. DOI: 10.1093/ofid/ofaa051.
Bavaro D.F., Papagni R., Belati A., et al. Cefiderocol versus colistin for the treatment of carbapenem-resistant Acinetobacter baumannii complex bloodstream infections: a retrospective, propensity-score adjusted monocentric cohort study // Infectious Diseases and Therapy. — 2023. — Vol. 12, No. 8. — P. 2147–2163. DOI: 10.1007/s40121-023-00854-6.
Bityukov S.L., Demidenko V.V. Effectiveness of using the Mannheim peritonitis index in predicting complications and mortality in diffuse peritonitis // Morphological Almanac named after V.G. Koveshnikov. — 2019. — Vol. 17, No. 3. — P. 14–18. — EDN KLNKHX.
Mildzikhov G.U., Pagieva M.K., Perisaeva E.A. Comprehensive treatment of patients with diffuse peritonitis and methods of preventing its complications // New developments in surgery, anaesthesiology and resuscitation. — 2015. — pp. 69–71. — EDN TBBXLN
Coccolini F., Sartelli M., Sawyer R., et al. Source control in emergency general surgery: WSES, GAIS, SIS-E, SIS-A guidelines // World J Emerg Surg. — 2023. — Vol. 18, No. 1. — Article 41. DOI: 10.1186/s13017-023-00509-4
De Pascale G., Posteraro B., D’Arrigo S., et al. (1,3)-β-D-glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomised trial // Critical Care. — 2020. — Vol. 24, No. 1. — Article 550. DOI: 10.1186/s13054-020-03265-y
De Waele J.J., Girardis M., Martin-Loeches I. Source control in the management of sepsis and septic shock // Intensive Care Med. — 2022. — Vol. 48, No. 12. — P. 1799–1802. DOI: 10.1007/s00134-022-06852-5
